---
title: "Contineum Therapeutics CSO Daniel S. Lorrain disposes of USD 16,640 in common shares"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292359507.md"
description: "Contineum Therapeutics CSO Daniel S. Lorrain sold 1,040 Class A common shares at $16 each on July 8-9, totaling $16,640. The sales followed the exercise of options for the same number of shares at $1.01. Post-transaction, Lorrain holds 135,202 direct shares and retains 33,257 exercisable stock options expiring in February 2030."
datetime: "2026-07-10T21:21:53.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292359507.md)
  - [en](https://longbridge.com/en/news/292359507.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292359507.md)
generator: "portal-rs"
---

# Contineum Therapeutics CSO Daniel S. Lorrain disposes of USD 16,640 in common shares

-   Contineum Therapeutics Chief Scientific Officer Daniel S. Lorrain sold 1,040 Class A common shares at USD 16 on July 8-9. \* Sales followed option exercises for 1,040 shares at USD 1.01, leaving direct ownership at 135,202 shares. \* He reported 33,257 stock options remaining, exercisable at USD 1.01, expiring Feb. 24, 2030. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Contineum Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-047909), on July 10, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [CTNM.US](https://longbridge.com/en/quote/CTNM.US.md)

## Related News & Research

- [Contineum Therapeutics CEO Carmine Stengone disposes of shares worth $40,029](https://longbridge.com/en/news/294743326.md)
- [Contineum Therapeutics CSO Daniel S. Lorrain disposes of USD 556,791 common shares](https://longbridge.com/en/news/291593149.md)
- [Rain Enhancement CEO Randy Seidl acquires 110,000 common shares valued at $104,225](https://longbridge.com/en/news/296545902.md)
- [LG Electronics deepens robotics collaboration with Nvidia](https://longbridge.com/en/news/296171747.md)
- [09:15 ETSEC's Proposed E-Delivery Rule Signals a New Era in Customer Communications](https://longbridge.com/en/news/296361991.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**